Neonatal Cardiac Transplantation
Authors:
- Mark M. BoucekMBMark M. Boucek
- Sandra L. Nehlsen-CannarellaSNSandra L. Nehlsen-Cannarella
- Steven R. GundrySGSteven R. Gundry
- Anees J. RazzoukARAnees J. Razzouk
- Leonard L. BaileyLBLeonard L. Bailey
- 1 September 1992
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 127 (9) , 1072-1076
Abstract
• Early age at cardiac transplantation may favor successful engrafting with minimal chronic immunosuppression. Fifty-two newborns underwent orthotopic heart transplantation; 47 (90%) survived the operation, and 44 (85%) were late survivors. Actuarial survival was 92% at 1 month, 86% at 1 year, and 84% at 5 years. Forty-four infants who survived 12 weeks and the corresponding 100 rejection episodes were analyzed. Mean follow-up was 2.2 years. The mean number of rejections per year of follow-up was 1.2. No episodes of rejection were identified in six patients. Seven patients had a late rejection episode more than 1 year after transplantation, and only one had a late rejection episode after 2 years. Neonatal cardiac transplantation is effective and durable therapy for uncorrectable heart disease. Intermediate-term results are excellent. Severe rejection is uncommon, and few episodes occur after 1 year of follow-up. (Arch Surg. 1992;127:1072-1076)Keywords
This publication has 3 references indexed in Scilit:
- HISTOCOMPATIBILITY AND OTHER RISK FACTORS FOR HISTOLOGICAL REJECTION OF HUMAN CARDIAC ALLOGRAFTS DURING THE FIRST THREE MONTHS FOLLOWING TRANSPLANTATIONTransplantation, 1991
- Cardiac transplantation with corticosteroid-free immunosuppression: Long-term resultThe Annals of Thoracic Surgery, 1991
- Another Look at Cardiac XenotransplantationJournal of Cardiac Surgery, 1990